Serum EGFR in patients with non-small cell lung cancer (NSCLC) treated with gefitinib

被引：0
|
作者：
Spreafico, A
Gregorc, V
Ludovini, V
Pistola, L
Amoroso, M
Tofanetti, F
Compagnoni, A
Aondio, G
Tonato, M
Villa, E
机构：
[1] San Raffaele Sci Inst, Div Oncol, I-20132 Milan, Italy
[2] Monteluce Policlin, Dept Med Oncol, Perugia, Italy
[3] Ist Mario Negri, Biometry Unit, Dept Oncol, Milan, Italy
[4] Morigga Pelascini Hosp, Div Med Oncol, Gravedona, Italy
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)80490-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S112 / S113
页数：2
相关论文
共 50 条
  • [1] Inherited EGFR variants and survival in patients with non-small cell lung cancer (NSCLC) treated with gefitinib.
    Gregorc, V
    Hidalgo, M
    Spreafico, A
    Aondio, G
    Cusatis, G
    Marsh, S
    Steinberg, SM
    Ludovini, V
    Villa, E
    Sparreboom, A
    Baker, SD
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9079S - 9079S
  • [2] Association of the EGFR gene polymorphisms with clinical outcomes in patients with advanced non-small cell lung cancer (NSCLC) treated with gefitinib
    Ma, F.
    Lin, D.
    Sun, T.
    Chu, D.
    Zhang, X.
    Wang, Z.
    Wang, J.
    Shi, Y.
    Sun, Y.
    Xu, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Longitudinal tumor dynamic modeling in non-small cell lung cancer (NSCLC) patients treated with gefitinib
    Xu, Hongmei
    Zhou, Diansong
    Tong, Xiao
    Al-Huniti, Nidal
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S39 - S39
  • [4] EGFR/KRAS-GERMLINE MUTATION ANALYSES IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH GEFITINIB/ERLOTINIB
    Tibaldi, C.
    Giovannetti, E.
    Vasile, E.
    Torti, D.
    Gallegos-Ruiz, M. I.
    Nannizzi, S.
    Del Tacca, M.
    Peters, G. J.
    Falcone, A.
    Danesi, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 106 - 106
  • [5] EGFR genomic gain in Japanese non-small cell lung cancer patients treated with gefitinib.
    Varella-Garcia, M.
    Mitsudomi, T.
    Yatabe, Y.
    Kosaka, T.
    Nakajima, E.
    Franklin, W.
    Bunn, P. A., Jr.
    Hirsch, F. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 405S - 405S
  • [6] EGFR mutation of tumor and serum in gefitinib-treated patients with chemotherapy-naive non-small cell lung cancer
    Kimura, Hideharu
    Kasahara, Kazuo
    Shibata, Kazuhiko
    Sone, Takashi
    Yoshimoto, Akihiro
    Kita, Toshiyuki
    Ichikawa, Yukari
    Waseda, Yuko
    Watanabe, Kazuyoshi
    Shiarasaki, Hiroki
    Ishiura, Yoshihisa
    Mizuguchi, Masayuki
    Nakatsumi, Yasuto
    Kashii, Tatsuhiko
    Kobayashi, Masashi
    Kunitoh, Hideo
    Tamura, Tomohide
    Nishio, Kazuto
    Fujimura, Masaki
    Nakao, Shinji
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (03) : 260 - 267
  • [7] Potential clinical prognostic factors in non-small cell lung cancer (NSCLC) patients treated with gefitinib.
    Villaflor, VM
    Polowy, CR
    Coon, JS
    Leslie, WT
    Lukic, I
    Kanevsky, G
    Gale, M
    Stewart, I
    Bonomi, P
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 638S - 638S
  • [8] Potential clinical prognostic factors in non-small cell lung cancer (NSCLC) patients treated with Gefitinib (Iressa)
    Villaflor, VM
    Polowy, CR
    Coon, J
    Leslie, W
    Lukic, I
    Kanevsky, G
    Gale, M
    Stewart, I
    Bonomi, P
    LUNG CANCER, 2004, 46 : S62 - S62
  • [9] Gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC)
    Bearz, Alessandra
    Fratino, Lucia
    Spazzapan, Simon
    Berretta, Massimiliano
    Giacalone, Annalisa
    Simonelli, Cecilia
    Tirelli, Umberto
    LUNG CANCER, 2007, 55 (01) : 125 - 127
  • [10] Exploratory analysis of EGFR FISH criteria in Japanese non-small cell lung cancer patients treated with gefitinib
    Kazuo, K.
    Morrison, L. E.
    Kimura, H.
    Sone, T.
    Araya, T.
    Tamori, S.
    Tanbo, Y.
    Fujimura, M.
    Speake, G.
    Holloway, B. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345